EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Advanced Glycation End-Products and Metabolomics Are Independently Associated With Frailty: The Longitudinal Doetinchem Cohort Study

Lieke M Kuiper iD, H Susan J Picavet, M Liset Rietman, Martijn E T Dollé, W M Monique Verschuren

The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences · 2025

DOI: 10.1093/gerona/glae272 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2025. Verfasst von Lieke M Kuiper und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Prevention, Lifestyle and Health, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands. Hauptthemen laut MEDLINE: Frailty, Glycation End Products, Advanced, Metabolomics, Skin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Netherlands Organization for Health Research and Development, Ministry of Health, Welfare and Sport of the Netherlands, National Institute for Public Health and the Environment.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Skin autofluorescence (SAF), reflecting advanced glycation endproducts’ accumulation in tissue, has been proposed as a noninvasive aging biomarker. Yet, SAF has not been compared with well-established blood-based aging biomarkers such as MetaboHealth in association with frailty. Furthermore, no previous study determined the longitudinal association of SAF with frailty. We used 2 382 Doetinchem Cohort Study participants’ (aged 46.0–85.4) cross-sectional data, of whom 1 654 had longitudinal SAF measurements. SAF was measured using the AGE Reader. MetaboHealth was calculated on 1H-NMR-metabolomics. Linear regressions were used for the associations of SAF and MetaboHealth on the 36-deficit frailty index and logistic regressions for being pre-frail or frail as determined by the frailty phenotype. Longitudinal associations were determined by an interaction term between age and SAF in a linear mixed model. SAF and MetaboHealth were associated with higher odds of pre-frailty (odd ratios per standard deviation SAF: 1.21 [1.10–1.32], MetaboHealth: 1.35 [1.24–1.49]) and frailty (SAF: 1.70 [1.41–2.06], MetaboHealth: 1.90 [1.57–2.32]). When mutually adjusted, both aging biomarkers remained associated with pre-frailty (SAF: 1.16 [1.05–1.27], MetaboHealth 1.33 [1.21–1.46]) and frailty (SAF: 1.52 [1.25–1.85], MetaboHealth: 1.75 [1.43–2.14]). Additionally, SAF and MetaboHealth were associated with higher frailty index scores (percentage increase per standard deviation SAF: 1.35 [1.00–1.70], MetaboHealth: 1.87 [1.54–2.20]), also after mutual adjustment (SAF: 1.02 [0.68–1.37], MetaboHealth: 1.69 [1.35–2.02]). SAF was also longitudinally associated with the frailty index (percentage per unit/year increase: 0.12 [0.07–0.16]). The mutual independence of SAF and MetaboHealth implies they capture distinct aspects of the aging process. Altogether, these findings emphasize SAF’s clinical potential as an age-related decline biomarker, which could be further enhanced when combined with MetaboHealth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FrailtyGlycation End Products, AdvancedMetabolomicsSkinAgingHumansMaleFemaleAgedMiddle AgedBiomarkersCross-Sectional StudiesLongitudinal StudiesAged, 80 and overOptical ImagingFrail Elderly

Stichwörter der Autor:innen

BiomarkersEpidemiologyHuman agingMetaboHealthMolecular

Substanzen

Glycation End Products, AdvancedBiomarkers

Autor:innen und Institutionen

  • Center for Prevention, Lifestyle and Health, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
  • Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
  • Center for Health Protection, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
  • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

ORCID-Profile: Lieke M Kuiper

Förderung

  • Netherlands Organization for Health Research and Development
  • Ministry of Health, Welfare and Sport of the Netherlands
  • National Institute for Public Health and the Environment

Zitieren

APA

Kuiper, L. M., Picavet, H. S. J., Rietman, M. L., Dollé, M. E. T., & Verschuren, W. M. M. (2025). Advanced Glycation End-Products and Metabolomics Are Independently Associated With Frailty: The Longitudinal Doetinchem Cohort Study. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. https://doi.org/10.1093/gerona/glae272

Vancouver

Kuiper LM, Picavet HSJ, Rietman ML, Dollé MET, Verschuren WMM. Advanced Glycation End-Products and Metabolomics Are Independently Associated With Frailty: The Longitudinal Doetinchem Cohort Study. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences. 2025. doi:10.1093/gerona/glae272

BibTeX
@article{Kuiper2025,
  author = {Kuiper, Lieke M and Picavet, H Susan J and Rietman, M Liset and Dollé, Martijn E T and Verschuren, W M Monique},
  title = {Advanced Glycation End-Products and Metabolomics Are Independently Associated With Frailty: The Longitudinal Doetinchem Cohort Study},
  journal = {The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences},
  year = {2025},
  doi = {10.1093/gerona/glae272}
}
Kostenlos starten →